Success Story: EB1B Approved in 15 Days Under Premium Processing! Our Expert Team Framed Immunology Impact Through Independent Reliance and Translational Continuity
Client’s Testimonial:
"Thank you for all your help in getting this petition approved.”
On February 27th, 2026, we received another EB-1B (Outstanding Professors and Researchers) approval for a Graduate Research Assistant in the Field of Immunology (Approval Notice).
General Field: Immunology
Position at the Time of Case Filing: Graduate Research Assistant
Country of Origin: Ghana
State of Residence at the Time of Filing: Connecticut
Approval Notice Date: February 27th, 2026
Processing Time: 15 days (Premium Processing Requested)
Case Summary:
North America Immigration Law Group (Chen Immigration Law Associates) is pleased to share an I-140 EB-1B (Outstanding Professor or Researcher) approval for the client, an immunology researcher whose work clarifies how antibody Fc receptor interactions regulate immune responses in infection and cancer. The petition was filed with premium processing and approved in 15 days, reflecting a record presented as field-recognized, sustained, and directly aligned with continued U.S. research work.
With a Ph.D. and an M.S. in immunology, the client’s research centers on how antibody Fc receptor interactions shape immune regulation and disease mechanisms. In the filing, we emphasized a consistent translational thread: using molecular immunology and antibody engineering to inform vaccine design, antibody therapies, and safer immune-based approaches for viral infections and cancer. The client is particularly well known for insights into bacterial immune interactions that help explain immune suppression and guide treatment strategies in cancer-related contexts.
At the time of filing, the client was employed in the United States as a senior research scientist in an academic medical research setting. The client’s ongoing work includes identifying novel tumor antigens by reverse engineering tumor-specific B cell receptors and using those findings to support next-generation cellular immunotherapy development, reinforcing that the client would continue in the same area of outstanding research.
EB-1B cases are strongest when the evidence shows more than productivity. The case must demonstrate that the field repeatedly treats the work as worth selecting, worth using, and worth building upon. We organized the record around that pattern and highlighted objective indicators in context:
- 32 peer-reviewed journal articles (4 first-authored), 1 first-authored abstract, and 1 preprint
- 4,015 citations to the published body of work
- Documented citation-performance context showing top-percentile influence within immunology benchmarks used in the petition materials
Peer-review service helps distinguish researchers whose expertise is relied upon by the broader community. The record documented at least 2 completed peer reviews. While peer review can be a common activity in some careers, the petition framed it as a trust signal that carries weight when paired with a highly cited research record and a sustained publication trajectory, showing the client is not only producing results but is also regarded as a capable evaluator of scientific rigor.
The petition included 2 letters of recommendation, including an independent perspective, to translate technical immunology contributions into clear significance and to corroborate that the client’s work has influenced how other specialists think about immune regulation in infection and cancer. One expert noted:
“[Client’s] research offers clear benefits to the United States healthcare system, particularly in pandemic response readiness, immunotherapy effectiveness, and the development of next-generation precision medicine approaches for both viral infections and cancer.”
The I-140 EB-1B petition was approved in 15 days under premium processing. The approval reflects a case record presented as outstanding in context, supported by a cohesive research direction, sustained peer-reviewed authorship, extensive independent citation reliance, documented research support, and expert testimony confirming the client’s influence in immunology.